Grasim Industries, Alkem Lab, Jubilant Foodworks, Berger Paints, Info Edge, and other stocks: Should you buy, hold or sell? Know what brokerages recommend

ZeeBiz WebTeam | Aug 12, 2024, 02:53 PM IST

The benchmark indexes Sensex and Nifty regained all of their early losses and were trading higher in the afternoon on Monday, August 12 buoyed by favourable global equity trends and fresh foreign capital inflows.

1/11

30-share BSE Sensex and Nifty50 today

30-share BSE Sensex and Nifty50 today

The 30-share BSE Sensex was 0.29 per cent or 229.4 points up at 79,935.30 while the NSE Nifty rose 57.60 points or 0.25 per cent, reaching 24,427.45 at 2.07 PM today.

2/11

Grasim Industries, Alkem Lab, Jubilant Foodworks, Berger Paints, Info Edge: Should you buy, sell, or hold these stocks?

Grasim Industries, Alkem Lab, Jubilant Foodworks, Berger Paints, Info Edge: Should you buy, sell, or hold these stocks?

Here's what Citi, JPMorgan, Macquarie, Morgan Stanley, Nomura, HSBC, Jefferies, and CLSA make of stocks Grasim Industries, Alkem Lab, Jubilant Foodworks, Berger Paints, Info Edge:

3/11

Should you buy/sell/hold Jubliant Foodworks shares?

Should you buy/sell/hold Jubliant Foodworks shares?

Jefferies and Citi have maintained a 'buy' rating on Jubilant Foodworks shares and increased the targets to Rs 850 and Rs 715 from Rs 475 and Rs 663, respectively. CLSA and Macquarie have given an 'underperform' rating, while Goldman Sachs and JP Morgan have given a 'neutral' rating on this stock. On the other hand, Morgan Stanley has maintained an 'eaqual-weight' rating. 

 

4/11

Should you buy/sell/hold Grasim Industries shares?

Should you buy/sell/hold Grasim Industries shares?

Morgan Stanley has maintained an 'equal-weight' rating with a target of Rs 2990.

 

5/11

Jefferies and Citi on Grasim Industries

Jefferies and Citi on Grasim Industries

Jefferies and Citi have maintained a 'buy' rating on Grasim Industries shares. The brokerages have increased the target to Rs 3,250 from Rs 3,000 and Rs 3,250 from Rs 3,000 respectively.

6/11

Should you buy/sell/hold Alkem Laboratories shares?

Should you buy/sell/hold Alkem Laboratories shares?

Jefferies and Macquarie have an 'underperform' call on Alkem Laboratories shares. The brokerages have raised target to Rs 5,080 and Rs 4,500 respectively.

 

7/11

JP Morgan and Nomura on Alkem Laboratories stock

JP Morgan and Nomura on Alkem Laboratories stock

On the other side, brokerages JP Morgan and Nomura have given 'neutral' rating on Alkem Laboratories stock. The targets have also been increased to Rs 5,870 and Rs 5,605 respectively.

8/11

Should you buy/sell/hold Berger Paints?

Should you buy/sell/hold Berger Paints?

Morgan Stanley has maintained an 'underweight' rating and has raised the target to Rs 439 from Rs 423. Nomura has given a 'sell' rating on Berger Paints stock and has raised the target to Rs 500 from Rs 450, while Macquarie has an 'underperform' call on the stock and the target has been revised to Rs 450 from Rs 435 previously.

9/11

Should you buy/sell/hold Info Edge India stock?

Should you buy/sell/hold Info Edge India stock?

Goldman Sachs: Maintained a 'sell' rating, target raised to Rs 5,700 from Rs 5,470.
Nomura: Maintained a 'buy' rating, target raised to Rs 8,280 from Rs 6,750.
Bernstein: Maintained an 'outperform' rating, target raised to Rs 7,940 from Rs 6,000.
Macquarie: Maintained an 'underperform' rating, given a target of Rs 4,150.

10/11

Should you buy/sell/hold Trent shares?

Should you buy/sell/hold Trent shares?

Morgan Stanley: Upgraded rating to 'over-weight' from 'equal-weight', target raised to Rs 5,700 from Rs 5,470.
Jefferies: Maintained a 'hold' rating, target raised to Rs 5,750 from Rs 4,150.

11/11

Should you buy/sell/hold Zydus Lifesciences shares?

Should you buy/sell/hold Zydus Lifesciences shares?

Jefferies: Maintained a 'hold' rating, target raised to Rs 1,210 from Rs 1,070.
JP Morgan: Maintained a 'neutral' rating, target raised to Rs 1,160 from Rs 965.
Macquarie: Maintained an 'outperform' rating, given a target of Rs 1,365. 
Nomura: Maintained a 'neutral' rating, target is Rs 1,020.

The views/suggestions/advice expressed here in this article are solely by the brokerage firm. Zee Business suggests its readers consult their investment advisers before making any financial decision.

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x